EU Risk Management Plan (RMP)

$18,000

Complete EU Risk Management Plan development per GVP Module V and EMA template requirements. Initial MAA RMPs, post-authorization updates, PRAC response support. Comprehensive safety specification, pharmacovigilance planning, and risk minimization measures. Full lifecycle management from submission through post-marketing. 10-14 weeks for initial RMP.

SKU: EV-RD-007 Category:

Description

<![CDATA[

EU Risk Management Plan (RMP) Development

The Risk Management Plan is a mandatory component of every Marketing Authorization Application in the European Union. An effective RMP demonstrates your comprehensive understanding of your product’s safety profile and your commitment to ongoing pharmacovigilance throughout the product lifecycle.

Editverse provides complete RMP development and lifecycle management services from initial MAA submission through post-authorization updates, ensuring your risk management strategy evolves with your product’s safety knowledge.


📋 What is an EU Risk Management Plan?

The RMP is a detailed description of the risk management system for a medicinal product, including:

  • 🔍 Safety Specification – Comprehensive characterization of the safety profile
  • 📊 Pharmacovigilance Plan – Activities to monitor identified and potential risks
  • 📋 Risk Minimization Measures – Actions to prevent or reduce risks
  • 📈 Effectiveness Evaluation – Assessment of risk minimization success

📜 Regulatory Framework

Regulation/GuidelineRequirement
Regulation (EU) 726/2004Centralized procedure requirements
Directive 2001/83/ECNational and decentralized procedure requirements
GVP Module VRisk Management Systems – detailed RMP guidance
GVP Module XVIRisk Minimization Measures guidance
EMA RMP TemplateCurrent RMP format requirements (Rev. 2.0.1)

📊 RMP Modules and Structure

ModulePartContent
Part IProduct OverviewProduct details, epidemiology, indication overview
Part IISafety SpecificationModule SI-SVIII including epidemiology, nonclinical, clinical trial exposure, post-marketing data
Part IIIPharmacovigilance PlanRoutine and additional PV activities, PASS studies
Part IVPost-Authorization Efficacy StudiesPAES plans if required
Part VRisk Minimization MeasuresRoutine and additional RMMs, effectiveness evaluation
Part VISummary of RMPPublic-facing summary for EPAR
Part VIIAnnexesSmPC, PL, mock-ups, educational materials, DHPC templates

🔍 Safety Specification Components (Part II)

  • Module SI – Epidemiology of indication(s)
  • Module SII – Nonclinical part of safety specification
  • Module SIII – Clinical trial exposure
  • Module SIV – Populations not studied in clinical trials
  • Module SV – Post-authorization experience
  • Module SVI – Additional EU requirements (ASMF, environmental risk)
  • Module SVII – Identified and potential risks
  • Module SVIII – Summary of safety concerns

📋 Service Options

ServiceDescriptionTimeline
Initial RMP (MAA)Complete RMP for new marketing authorization application10-14 weeks
RMP UpdatePeriodic update (new data, PSUR alignment, PRAC request)4-8 weeks
Variation-Triggered UpdateRMP revision for Type II variation or line extension4-6 weeks
PRAC ResponseResponse to PRAC questions on RMP2-4 weeks
RMP Gap AnalysisAssessment of existing RMP against current requirements2-3 weeks

⚙️ Development Workflow

PhaseActivitiesDuration
1. Risk AssessmentSafety data review, risk identification, safety concern categorizationWeek 1-3
2. Safety SpecificationDraft all safety specification modulesWeek 3-6
3. PV & RMM PlansDevelop pharmacovigilance and risk minimization strategiesWeek 6-9
4. AnnexesPrepare educational materials, DHPC templates if neededWeek 8-10
5. Internal ReviewPV expert and regulatory reviewWeek 10-11
6. Sponsor ReviewClient review and comment resolutionWeek 11-13
7. FinalizationFinal QC, EMA template compliance checkWeek 13-14

✨ Why Choose Editverse

FeatureBenefit
GVP ExpertiseWriters trained in GVP Modules V and XVI requirements
PRAC ExperienceFamiliarity with common PRAC questions and expectations
SmPC/PL AlignmentEnsuring consistency between RMP and product labeling
Template ComplianceUp-to-date with latest EMA RMP template requirements
Lifecycle SupportOngoing RMP maintenance and update services

📦 Deliverables

  • Complete RMP Document – All parts and modules per EMA template
  • Summary of RMP – Public-facing version for EPAR
  • Risk Minimization Materials – Educational materials, HCP guides if required
  • DHPC Templates – Direct Healthcare Professional Communication drafts
  • Version Control – Complete change tracking and version history

📞 Get Started

Contact us to discuss your product’s risk management needs:

📧 Email: co*****@*******se.com
🌐 Web: editverse.com

Pricing provided in your local currency. Bundled with MAA writing services for comprehensive submission support.

]]>